After Credit Suisse and Barclays gave HCA Healthcare (NYSE: HCA) a Buy rating last month, the company received another Buy,
Addus Homecare Co. (NASDAQ:ADUS) has earned a consensus recommendation of “Hold” from the ten brokerages that are currently covering the firm, MarketBeat.com reports. One investment analyst has ra
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Addus Homecare (ADUS), with a price target of $98.00. The company's
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Addus Homecare ( ADUS – Research Report ), with a price target of $98.00 . The company’s shares closed last Fri
Wall Street brokerages predict that Addus Homecare Co. (NASDAQ:ADUS) will post $0.64 earnings per share for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for Addus H
Wall Street analysts expect that Addus Homecare Co. (NASDAQ:ADUS) will post $181.08 million in sales for the current quarter, Zacks Investment Research reports. Five analysts have provided estimates f
Alliancebernstein L.P. lifted its holdings in shares of Addus Homecare Co. (NASDAQ:ADUS) by 7.4% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investo
6 Meridian acquired a new stake in Addus Homecare Co. (NASDAQ:ADUS) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acq
Addus Homecare Co. (NASDAQ:ADUS) – Investment analysts at Oppenheimer decreased their Q1 2020 earnings estimates for Addus Homecare in a research note issued to investors on Sunday, April 12th. Oppe
Goldman Sachs Group Inc. lifted its holdings in shares of Addus Homecare Co. (NASDAQ:ADUS) by 152.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and
Over the past weekend, the U.S. Centers for Medicare & Medicaid Services distributed $30B of the planned $100B in CARES Act grants to healthcare providers as they battle COVID-19.The distribution
Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Addus Homecare (ADUS – Research Report) today and set a price
Zacks Investment Research cut shares of Addus Homecare (NASDAQ:ADUS) from a strong-buy rating to a hold rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “ADDUS HOMECA
Addus Homecare Co. (NASDAQ:ADUS) – Stock analysts at William Blair cut their Q2 2020 earnings per share (EPS) estimates for Addus Homecare in a research report issued to clients and investors on Tue
Addus Homecare Co. (NASDAQ:ADUS) – Analysts at William Blair reduced their Q1 2020 EPS estimates for shares of Addus Homecare in a research note issued to investors on Tuesday, April 7th. William Bl
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE